IIT Kharagpur’s innovative solution
In a world where the diagnosis of oral cancer often relies on subjective assessments and sophisticated resources remain out of reach for many, Suman Chakraborty and Arka Bhowmik from the Indian Institute of Technology Kharagpur have introduced an innovative and accessible solution. Their pioneering work addresses the pressing clinical challenge of distinguishing oral cancer, including oral squamous cell carcinoma, from benign conditions, which often present deceptively similar features.
The conventional diagnostic journey for oral cancer is fraught with difficulties. Clinicians are often forced to rely solely on their subjective judgment, assessing various recognizable features of high-risk oral sites such as the buccal mucosa, tongue, gum, and palate, in addition to considering the patient’s medical history. This reliance on subjective assessment can lead to misdiagnosis or delayed diagnosis, with potentially fatal consequences.
Chakraborty and Bhowmik’s groundbreaking platform technology offers a user-friendly and affordable solution to this critical issue. Their portable handheld device, reminiscent of a torch, is equipped with an array of sensors and controllers. This ingenious device processes thermal images captured inside the oral cavity in a completely touch-free manner. It then translates these thermal images into valuable blood perfusion data using a novel algorithm.
What sets this technology apart is its ability to harness artificial intelligence (AI). The blood-perfusion data collected by the device is fed into an AI-driven analytical engine. This engine is capable of classifying oral conditions with exceptional accuracy, distinguishing between normal, pre-cancerous, and cancerous states within the oral cavity. This eliminates the need for patients to be referred to specialized medical centers for resource-intensive diagnostic procedures, streamlining the diagnosis process and reducing the burden on healthcare systems.
Furthermore, this innovative platform technology boasts a unique feature: its generic blood-perfusion-based scientific foundation enables it to be readily adaptable to detect a myriad of other diseases stemming from microvascular flow abnormalities. This versatility extends its applications beyond oral cancer to include different types of oral diseases, diabetic wounds, and even skin cancer.
In an era where accessibility to advanced healthcare technology remains a challenge for many, Chakraborty and Bhowmik’s all-inclusive platform stands as a beacon of hope. It offers an affordable, accessible, and portable framework for disease detection that is sorely lacking in the current healthcare landscape.
This groundbreaking technology has already received recognition, with patents secured and publications in prestigious journals such as the Proceedings of the National Academy of Sciences, USA. Additionally, it has undergone successful testing in a phase-1 clinical trial, further validating its potential to revolutionize disease detection and healthcare accessibility.
In summary, Suman Chakraborty and Arka Bhowmik’s innovative noninvasive blood perfusion-based screening technology represent a significant leap forward in disease detection, with the potential to save lives and improve healthcare accessibility on a global scale.
For further details contact Suman at suman@mech.iitkgp.ac.in
–Raja Aditya
